Faulkingham Dell
Insider CIK 1776024 · AKBA SVP, CCO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 5,748 | $2.17 | $12.5K | 174,798 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 957 | $2.17 | $2.1K | 173,841 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-02 | 6,479 | $2.15 | $13.9K | 130,546 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-02-28 | 2022-03-02 | 50,000 | — | $0 | 180,546 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-01 | 952 | $3.40 | $3.2K | 137,025 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-03-16 | 2021-03-18 | 9,152 | — | $0 | 137,977 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 6,749 | $3.40 | $22.9K | 128,825 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-02-26 | 2021-03-02 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-02-26 | 2021-03-02 | 62,000 | — | $0 | 135,574 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2020-06-01 | 2020-06-02 | 6,426 | $11.58 | $74.4K | 73,574 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-02 | 94,000 | — | $0 | 94,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-02 | 55,000 | — | $0 | 80,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-05-31 | 2019-06-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-05-31 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |